Group E—Evidence of Noncarcinogenicity for Humans

Group E Evidence of noncarcinogenicity for humans Agents that show no evidence for carcinogenicity in at least two adequate animal tests in different species or in both adequate epidemiologic and animal studies... 

Researchers have examined the possible effects of aldicarb on the induction of peripheral neuropathies. Currently, insufficient evidence exists to indicate any significant long-term health risk associated with aldicarb exposure. The US Environmental Protection Agency s (EPA) Office of Pesticide Programs has classified aldicarb as group E - evidence of noncarcinogenicity for humans. 

---